ArticleThe Journal of investigative dermatology2026
Post-trial provisions: Unblinding after a randomized blinded trial of spironolactone or doxycycline to treat acne in women.
John S Barbieri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.